Share on :

Asset Summary

No data available for Daily Sep 17, 2024, .

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Optimize Your BIB Trading Now

Discover unparalleled trading insights with RankMyTrade. Our automated system offers advanced analysis and technical indicators for BIB, aimed at optimizing your trading decisions. Elevate your trading approach instantly and get ahead in the market now!

Experience Excellence Now

Frequently Asked Questions

Key performance metrics for BIB include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. BIB's performance is designed to be twice that of the S&P Biotechnology Select Industry Index on a daily basis.

BIB typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF, though leveraged ETFs may have lower yield compared to non-leveraged funds.

Similar ETFs to BIB include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide three times the daily performance of the S&P Biotechnology Select Industry Index; IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotechnology and pharmaceutical companies; and XBI (SPDR S&P Biotech ETF), which tracks the S&P Biotechnology Select Industry Index and provides broad exposure to the biotech sector.

Yes, BIB can be held in retirement accounts such as IRAs or 401(k)s. However, due to its leveraged nature and higher risk profile, it’s important to consider how it fits within your overall investment strategy and risk tolerance.

BIB uses leverage to amplify its exposure to the biotechnology sector, aiming for twice the daily performance of the S&P Biotechnology Select Industry Index. Leverage can result in significant fluctuations in performance, especially over periods longer than one day due to daily compounding.

BIB is managed by ProShares and seeks to achieve its investment objective by using financial instruments, including derivatives such as futures contracts, options, and swap agreements. It aims to provide leveraged exposure to the biotechnology sector.

Factors influencing BIB’s performance include movements in the biotechnology sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. The ETF’s performance is also impacted by its daily rebalancing and compounding effects.

BIB has an expense ratio of approximately 0.95%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

BIB rebalances its holdings daily to maintain its leverage ratio of 2x the daily performance of the S&P Biotechnology Select Industry Index. This daily rebalancing can lead to differences in performance over time compared to the index due to the effects of compounding.

Investors can purchase shares of BIB through a brokerage account. It is traded on major stock exchanges under the ticker symbol "BIB" and can be bought and sold like other stocks and ETFs.

Unlock Your BIB Trading Now

Unlock the full potential of BIB with Rank My Trade Platform’s cutting-edge automated trading system. Our platform provides precise price action analysis, advanced technical indicators, and powerful quantitative algorithms. Boost your investment success with us and transform your trading experience today!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs